Nicole Skoetz has been active in Cochrane since 2002, first as a Consumer Co-ordinator and author, then as Managing Editor and since 2011 as Co-ordinating Editor of Cochrane Haematological Malignancies Review Group (CHM). She has also been actively involved in a number of committees, including the Scientific Committee, Prognosis Implementation Strategy Group, Methods Application and Review Standards, and the Co-Eds Executive. By leading Cochrane Cancer right from the beginning in 2014, Nicole has worked to bundle expertise from Cochrane Review Groups (CRGs) and Methods Groups to identify gaps in review production in the field of cancer; engage with stakeholders; collaborate with external international cancer organizations; and apply collaboratively for funding.
Nicole have also been active in identifying high-priority research areas to gain funding. She authored two Cochrane exemplar protocols on prognosis - one on prognostic factors and another one on prediction models, both funded by the Federal Ministry of Education and Research (BMBF). She also secured funding from BMBF to conduct five cancer-related network meta-analyses. She also has experience as a guideline developer, including a strong interest in interactive summary of finding tables and using GRADE effectively.